Overexpression of tRFLeu − CAG increased the activity of AURKA and then promoted cell cycle progression at the G0/G1 phase in non-small cell lung cancer (NSCLC) [26, 27]. The gene discussed is AURKA; the disease is non-small cell lung carcinoma.